R. F. Robinson, Impact of respiratory syncytial virus in the United States, Am. J. Health Syst. Pharm, vol.65, pp.3-6, 2008.

A. S. Monto, Epidemiology of viral respiratory infections, Am. J. Med, vol.112, issue.6A, pp.4-12, 2002.

M. K. Iwane, K. M. Edwards, P. G. Szilagyi, F. J. Walker, M. R. Griffin et al., Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children, Pediatrics, vol.113, pp.1758-1764, 2004.

S. S. Mohapatra and S. Boyapalle, Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma, Clin. Microbiol. Rev, vol.21, pp.495-504, 2008.

N. Sigurs, F. Aljassim, B. Kjellman, P. D. Robinson, F. Sigurbergsson et al., Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life, Thorax, vol.65, pp.1045-1052, 2010.

K. N. Carroll, P. Wu, T. Gebretsadik, M. R. Griffin, W. D. Dupont et al., The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma, J. Allergy Clin. Immunol, vol.123, p.1, 2009.

F. D. Martinez, A. L. Wright, L. M. Taussig, C. J. Holberg, M. Halonen et al., Asthma and wheezing in the first six years of life. The Group Health Medical Associates, N. Engl. J. Med, vol.332, pp.133-138, 1995.

K. J. Mackenzie, S. M. Anderton, and J. Schwarze, Viral respiratory tract infections and asthma in early life: cause and effect?, Clin Exp. Allergy: J. Brit. Soc. Allergy Clin. Immunol, vol.44, pp.9-19, 2014.

P. S. Mcnamara, P. Ritson, A. Selby, C. A. Hart, and R. L. Smyth, Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis, Arch. Dis. Child, vol.88, pp.922-926, 2003.

M. K. Lay, P. A. Gonzalez, M. A. Leon, P. F. Cespedes, S. M. Bueno et al., Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response, Microbes Infect, vol.15, pp.230-242, 2013.

M. A. Fiedler, K. Wernke-dollries, and J. M. Stark, Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells, Am. J. Physiol, vol.269, pp.865-872, 1995.

L. H. Thomas, J. S. Friedland, M. Sharland, and S. Becker, Respiratory syncytial virusinduced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha, J. Immunol, vol.161, pp.1007-1016, 1998.

P. Jaovisidha, M. E. Peeples, A. A. Brees, L. R. Carpenter, and J. N. Moy, Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release, J. Immunol, vol.163, pp.2816-2820, 1999.

R. Villenave, S. Thavagnanam, S. Sarlang, J. Parker, I. Douglas et al., In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo, Proc. Natl. Acad. Sci. USA, vol.109, pp.5040-5045, 2012.

M. Roman, W. J. Calhoun, K. L. Hinton, L. F. Avendano, V. Simon et al., Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response, Am. J. Respir. Crit. Care Med, vol.156, pp.190-195, 1997.

D. R. Ehlenfield, K. Cameron, and R. C. Welliver, Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease, Pediatrics, vol.105, pp.79-83, 2000.

D. S. Robinson, Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans et al., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma, N. Engl. J. Med, vol.326, pp.298-304, 1992.

P. J. Openshaw, S. L. Clarke, and F. M. Record, Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G, Int. Immunol, vol.4, pp.493-500, 1992.

C. C. Hui, D. M. Murphy, H. Neighbour, M. Al-sayegh, S. O'byrne et al., T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells, Clin. Exp. Allergy: J. Brit. Soc. Allergy Clin. Immunol, vol.44, pp.953-964, 2014.

J. Beale, Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation, Sci. Transl. Med, vol.6, issue.256, 2014.

D. J. Jackson, IL-33-Dependent type 2 inflammation during rhinovirusinduced asthma exacerbations in vivo, Am. J. Respir. Crit. Care Med, vol.190, issue.12, pp.1373-1382, 2014.

A. Yagami, K. Orihara, H. Morita, K. Futamura, N. Hashimoto et al., IL-33 mediates inflammatory responses in human lung tissue cells, J. Immunol, vol.185, pp.5743-5750, 2010.

A. G. Besnard, D. Togbe, N. Guillou, F. Erard, V. Quesniaux et al., IL-33-activated dendritic cells are critical for allergic airway inflammation, Eur. J. Immunol, vol.41, pp.1675-1686, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00935078

A. Al-shami, R. Spolski, J. Kelly, A. Keane-myers, and W. J. Leonard, A role for TSLP in the development of inflammation in an asthma model, J. Exp. Med, vol.202, pp.829-839, 2005.

P. Sheeran, H. Jafri, C. Carubelli, J. Saavedra, C. Johnson et al., Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease, Pediatr. Infect. Dis. J, vol.18, pp.115-122, 1999.

C. W. Bierman and W. E. Pierson, The pharmacologic management of status asthmaticus in children, Pediatrics, vol.54, pp.245-247, 1974.

A. Tal, C. Bavilski, D. Yohai, J. E. Bearman, R. Gorodischer et al., Dexamethasone and salbutamol in the treatment of acute wheezing in infants, Pediatrics, vol.71, pp.13-18, 1983.

T. C. Lewis, T. A. Henderson, A. R. Carpenter, I. A. Ramirez, C. L. Mchenry et al., Nasal cytokine responses to natural colds in asthmatic children, Clin. Exp. Allergy: J. Brit. Soc. Allergy Clin. Immunol, vol.42, pp.1734-1744, 2012.

J. E. Gern, G. D. Brooks, P. Meyer, A. Chang, K. Shen et al., Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life, J. Allergy Clin. Immunol, vol.117, pp.72-78, 2006.

A. Dakhama, Y. M. Lee, and E. W. Gelfand, Virus-induced airway dysfunction: pathogenesis and biomechanisms, Pediatr. Infect. Dis. J, vol.24, pp.159-169, 2005.

J. F. Bermejo-martin, M. C. Garcia-arevalo, R. O. De-lejarazu, J. Ardura, J. M. Eiros et al., Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children, Eur. Cytokine Netw, vol.18, pp.162-167, 2007.

M. Martinez-moczygemba and D. P. Huston, Biology of common beta receptorsignaling cytokines: IL-3, IL-5, and GM-CSF, J. Allergy Clin. Immunol, vol.112, pp.653-665, 2003.

J. P. Legg, I. R. Hussain, J. A. Warner, S. L. Johnston, and J. O. Warner, Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis, Am. J. Respir. Crit. Care Med, vol.168, pp.633-639, 2003.

L. Bont, A. Kavelaars, C. J. Heijnen, A. J. Van-vught, and J. L. Kimpen, Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis, J. Infect. Dis, vol.181, pp.1772-1775, 2000.

M. K. Gately, L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini et al., The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses, Annu. Rev. Immunol, vol.16, pp.495-521, 1998.

S. Gillessen, D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo et al., Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist, Eur. J. Immunol, vol.25, pp.200-206, 1995.

F. J. Podlaski, V. B. Nanduri, J. D. Hulmes, Y. C. Pan, W. Levin et al., Molecular characterization of interleukin, vol.12, pp.230-237, 1992.

P. Ling, M. K. Gately, U. Gubler, A. S. Stern, P. Lin et al., Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity, J. Immunol, vol.154, pp.116-127, 1995.

J. R. Piccotti, S. Y. Chan, R. E. Goodman, J. Magram, E. J. Eichwald et al., IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity, J. Immunol, vol.157, pp.1951-1957, 1996.

E. Duvallet, L. Semerano, E. Assier, G. Falgarone, and M. C. Boissier, Interleukin-23: a key cytokine in inflammatory diseases, Ann. Med, vol.43, pp.503-511, 2011.

K. J. Mobbs, R. L. Smyth, U. O'hea, D. Ashby, P. Ritson et al., Cytokines in severe respiratory syncytial virus bronchiolitis, Pediatr. Pulmonol, vol.33, pp.449-452, 2002.

C. K. Kim, S. W. Kim, C. S. Park, B. I. Kim, H. Kang et al., Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis, J. Allergy Clin. Immunol, vol.112, pp.64-71, 2003.

P. S. Mcnamara, B. F. Flanagan, C. A. Hart, and R. L. Smyth, Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis, J. Infect. Dis, vol.191, pp.1225-1232, 2005.

P. S. Mcnamara, A. M. Fonceca, D. Howarth, J. B. Correia, J. R. Slupsky et al., Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF, Thorax, vol.68, pp.76-81, 2013.

C. Garcia, A. Soriano-fallas, J. Lozano, N. Leos, A. M. Gomez et al., Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis, Pediatr. Infect. Dis. J, vol.31, pp.86-89, 2012.

C. M. Tabarani, C. A. Bonville, M. Suryadevara, P. Branigan, D. Wang et al., Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection, Pediatr. Infect. Dis. J, vol.32, pp.437-442, 2013.

R. P. Garofalo, J. Patti, K. A. Hintz, V. Hill, P. L. Ogra et al., Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis, J. Infect. Dis, vol.184, pp.393-399, 2001.

T. L. Noah, S. S. Ivins, P. Murphy, I. Kazachkova, B. Moats-staats et al., Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis, Clin. Immunol, vol.104, pp.86-95, 2002.

A. Hornsleth, L. Loland, and L. B. Larsen, Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection, J. Clin. Virol, vol.21, pp.163-170, 2001.

S. A. Saenz, B. C. Taylor, and D. Artis, Welcome to the neighborhood: epithelial cellderived cytokines license innate and adaptive immune responses at mucosal sites, Immunol. Rev, vol.226, pp.172-190, 2008.